Cravens & Co Advisors’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$798K Sell
4,538
-1,834
-29% -$269K 0.54% 39
2026
Q1
$785K Buy
6,372
+135
+2% +$17.7K 0.51% 39
2025
Q4
$917K Sell
6,237
-2
-0% -$235 0.6% 35
2025
Q3
$593K Buy
6,239
+2,561
+70% +$254K 0.4% 43
2025
Q2
$351K Buy
+3,678
New +$298K 0.26% 43

Other funds holding ILMN

Cravens & Co Advisors's ILMN Position: Q2 2026 in Review

Cravens & Co Advisors reduced its Illumina (ILMN) stake by 29% in Q2 2026, selling an estimated $269K and leaving 4,538 shares worth $798K. The position accounts for 0.54% of the portfolio, ranked #39.

Cravens & Co Advisors first reported a position in ILMN in Q2 2025 and has held it in 5 quarters since. The position peaked at $917K in Q4 2025. 937 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

  • Cravens & Co Advisors held 4,538 shares of Illumina worth $798K as of Q2 2026.
  • Cravens & Co Advisors sold 1,834 Illumina shares in Q2 2026, an estimated $269K.
  • Illumina made up 0.54% of Cravens & Co Advisors's portfolio in Q2 2026, its #39 holding.
  • Cravens & Co Advisors first reported a position in Illumina in Q2 2025 and has held it in 5 quarters since.
  • Cravens & Co Advisors's Illumina position peaked at $917K in Q4 2025.
  • 937 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on Cravens & Co Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.